Phase 1 Study of ADI PEG 20 Plus FOLFOX in Subjects With Advanced Gastrointestinal Malignancies
Phase of Trial: Phase I
Latest Information Update: 17 Jun 2017
At a glance
- Drugs Pegargiminase (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Gastrointestinal cancer; Liver cancer
- Focus Adverse reactions
- Sponsors Polaris Pharmaceuticals
- 21 Jan 2017 Results (n=17) presented at the 2017 Gastrointestinal Cancers Symposium
- 10 Aug 2016 Planned number of patients changed from 22 to 148.
- 10 Aug 2016 Planned End Date changed from 1 Mar 2017 to 1 Oct 2017.